Showing results (71-80 of 173) with videos related to

Sort By:
Pageof 18
British Journal of Haematology|September 20, 2011
Promising therapy results for lymphoid malignancies in children with chromosomal breakage syndromes (Ataxia teleangiectasia or Nijmegen-breakage syndrome): a retrospective surveyKlaus Bienemann, Birgit Burkhardt, Simon Modlich, et al.
Haematologica|March 2, 2016
Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivationInge M van der Sluis, Lynda M Vrooman, Rob Pieters, et al.
Leukemia|March 24, 2020
Leukemia-induced dysfunctional TIM-3+CD4+ bone marrow T cells increase risk of relapse in pediatric B-precursor ALL patientsFranziska Blaeschke, Semjon Willier, Dana Stenger, et al.
Haematologica|August 5, 2021
Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study GroupGabriele Escherich, Udo Zur Stadt, Arndt Borkhardt, et al.
Nature Communications|June 27, 2025
Role of stem-like cells in chemotherapy resistance and relapse in pediatric T-cell acute lymphoblastic leukemiaJulia Costea, Kerstin K Rauwolf, Pietro Zafferani, et al.
Scientific Reports|March 16, 2019
Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemiaElisabeth M P Steeghs, Judith M Boer, Alex Q Hoogkamer, et al.
Blood|June 10, 2021
miR-130b and miR-128a are essential lineage-specific codrivers of t(4;11) MLL-AF4 acute leukemiaCamille Malouf, Eric T B Antunes, Michael O'Dwyer, et al.
International Journal of Dermatology|July 21, 2021
Mucha-Habermann disease: a pediatric case report and proposal of a risk scoreMartin Ernst Blohm, Chinedu Ulrich Ebenebe, Cornelius Rau, et al.
Haematologica|February 19, 2011
The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97)Gabriele Escherich, Anja Tröger, Ulrich Göbel, et al.
Haematologica|June 12, 2013
Pediatric Acute Lymphoblastic Leukemia: Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemiaInge van der Sluis, Anja Möricke, Gabriele Escherich, et al.
Pageof 18